Vitor Cabral
Impact in
- Molecular Medicine top 2%
- Curcumin's Biomedical Applications
- Rehabilitation top 5%
- Wound Healing and Treatments
Papers in
-
- Antifungal resistance and susceptibility 6
- Clostridium difficile and Clostridium perfringens research 3
-
- Gut microbiota and health 4
- Bacterial biofilms and quorum sensing 2
- CRISPR and Genetic Engineering 2
- Co-authors
- Harris H. Wang (2 shared papers)Sway P. Chen (2 shared papers)Ravi U. Sheth (1 shared paper)Stephanie J. Yaung (1 shared paper)Joshua D. Nosanchuk (3 shared papers)Carlotta Ronda (1 shared paper)Adam Friedman (2 shared papers)Leslie Gunther (1 shared paper)
- Journals
- Nature Methods (1 paper)Scientific Reports (1 paper)Molecular Microbiology (1 paper)Cell Host & Microbe (1 paper)Antimicrobial Agents and Chemotherapy (1 paper)
- Partner nations
- United StatesPortugalFrance
In The Last Decade
Vitor Cabral
15 papers receiving 1.1k citations
Hit Papers
Peers
Comparison fields: 5 of 114
- Molecular Medicine 198
- Rehabilitation 137
- Pharmaceutical Science 87
- Infectious Diseases 259
- Biomaterials 122
Countries citing papers authored by Vitor Cabral
This map shows the geographic impact of Vitor Cabral's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Vitor Cabral with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Vitor Cabral more than expected).
Fields of papers citing papers by Vitor Cabral
This network shows the impact of papers produced by Vitor Cabral. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Vitor Cabral. The network helps show where Vitor Cabral may publish in the future.
Co-authors
The 25 scholars most cited alongside Vitor Cabral, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Curcumin-encapsulated nanoparticles as innovative antimicrobial and wound healing agent Hit paper breakdown → | 2014 | 388 |
| 2 | 2016 | 190 | |
| 3 | 2019 | 177 | |
| 4 | 2020 | 83 | |
| 5 | 2012 | 80 | |
| 6 | 2014 | 49 | |
| 7 | 2016 | 44 | |
| 8 | 2023 | 32 | |
| 9 | 2017 | 23 | |
| 10 | 2018 | 21 | |
| 11 | 2023 | 13 | |
| 12 | 2012 | 11 | |
| 13 | 2017 | 2 | |
| 14 | 2025 | 1 | |
| 15 | 2022 | 1 |
About Vitor Cabral
Vitor Cabral is a scholar working on Infectious Diseases, Molecular Biology, Epidemiology, Food Science and Pulmonary and Respiratory Medicine, having authored 15 papers that have together received 1.1k indexed citations. Recurring topics across this work include Antifungal resistance and susceptibility (6 papers), Fungal Infections and Studies (4 papers), Gut microbiota and health (4 papers), Clostridium difficile and Clostridium perfringens research (3 papers), Probiotics and Fermented Foods (3 papers), Bacterial biofilms and quorum sensing (2 papers), CRISPR and Genetic Engineering (2 papers) and Peptidase Inhibition and Analysis (2 papers). The work is most often cited by research in Molecular Medicine (198 citations), Rehabilitation (137 citations), Pharmaceutical Science (87 citations), Infectious Diseases (259 citations) and Biomaterials (122 citations). Vitor Cabral has collaborated with scholars based in United States, Portugal and France. Frequent co-authors include Harris H. Wang, Sway P. Chen, Ravi U. Sheth, Stephanie J. Yaung, Joshua D. Nosanchuk, Carlotta Ronda, Adam Friedman, Leslie Gunther, Aimee E. Krausz and Stacey L. Harper. Their work appears in journals such as Nature Methods, Scientific Reports, Molecular Microbiology, Cell Host & Microbe and Antimicrobial Agents and Chemotherapy.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.